RPG Life Sciences Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 6,966 shares,. Its Average Traded Price (ATP) is ₹2543.85, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 8 @ ₹2553.70.
RPG Life Sciences has an upper circuit limit of ₹3064.40 and a lower circuit limit of ₹2043.00. The total value traded stands at ₹1.77 CR, and the delivery percentage for the day is 54.5%.
The stock is currently traded with a market lot size of 1. RPG Life Sciences also offers a dividend yield of 0.94%.
RPG Life Sciences Share Price Chart
RPG Life Sciences Share Key Metrics
Volume
6966.00
Market Cap
4223.57 CR
LTQ@LTP
8@2553.70
ATP
2543.85
Var Margin
22.5 %
Circuit Range
2043-3064.4
Delivery %
54.5 %
Value
1.77 CR
ASM/GSM
No
Market Lot
1
RPG Life Sciences Resistance and Support
Pivot 2600.6
Resistance
First Resistance
2629.1
Second Resistance
2662.5
Third Resistance
2691
Support
First Support
2567.2
Second Support
2538.7
Third Support
2505.3
RPG Life Sciences Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
RPG Life Sciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-28 | Quarterly Results |
| 2026-04-29 | Audited Results & Final Dividend |
| 2026-01-27 | Quarterly Results |
| 2025-10-17 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-04-28 | Audited Results & Final Dividend |
| 2025-01-24 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-09 | 2026-07-09 | View More |
RPG Life Sciences News
RPG Life Sciences Ltd - 532983 - Amendment To Policy
RPG Life Sciences board approved Q2 & H1 FY27 financial results. The board also approved the revised policy on related party transactions, which will be available on the company's website.
Oct 29 2026 22:19:10
RPG Life Sciences Ltd - 532983 - Board Meeting Outcome for Outcome Of Board Meeting
RPG Life Sciences reported Q2 FY27 cons. revenue of ₹211.64 crores (up 16.5% YoY) and net profit of ₹28.22 crores (down 23.4% YoY). The financials reflect the recent acquisitions of Actis Generics and the API business of Raghava Life Sciences.
Oct 29 2026 21:38:02
RPG Life Sciences Ltd - 532983 - Board Meeting Intimation for For Quarter And Half Year Ended September 30, 2026
RPG Life Sciences announced a board meeting scheduled for October 29, 2026. The board will consider and approve the financial results for the quarter and half-year ended September 30, 2026.
Oct 22 2026 20:57:36
RPG Life Sciences Management
| Name | Position |
|---|---|
| Harsh Goenka | Chairman |
| Ashok Nair | Managing Director |
RPG Life Sciences Similar Stocks
Senores Pharmaceuticals Ltd.
1161.00
-26.90 (2.26%)
Supriya Lifescience Ltd.
695.80
-173.80 (19.99%)
Sahajanand Medical Technologies Ltd.
525.95
38.20 (7.83%)
SMS Pharmaceuticals Ltd.
498.55
-18.15 (3.51%)
Artemis Medicare Services Ltd.
306.10
4.90 (1.63%)
Gufic Biosciences Ltd.
430.35
-4.10 (0.94%)
Aarti Drugs Ltd.
446.75
1.60 (0.36%)
Kwality Pharmaceuticals Ltd.
3644.80
-42.50 (1.15%)
Indraprastha Medical Corporation Ltd.
330.20
-3.55 (1.06%)
Unichem Laboratories Ltd.
501.70
8.40 (1.70%)
RPG Life Sciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in RPGLIFE
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC